ABSTRACT
BACKGROUND: In Switzerland each year, influenza leads to between 112,000 and 275,000 medical consultations. Data on nosocomial influenza infection are limited. AIM: To describe nosocomial cases of seasonal influenza in south-western Switzerland. METHODS: This study was conducted during two seasonal influenza epidemics from 2016 to 2018 in 27 acute care public hospitals in south-western Switzerland. During these two time-periods, every patient hospitalized for >72 h who was positively screened by reverse transcription-polymerase chain reaction or antigen detection for influenza was included in the survey. Characteristics of patients included age, sex, and comorbidities. Included patients were followed up until discharge or death. Complications and administration of antineuraminidases and/or antibiotics were registered. FINDINGS: The median influenza vaccine coverage of healthcare workers was 40%. In all, 836 patients were included (98% with type A influenza virus in 2016-2017; 77% with type B virus in 2017-2018). Most patients (81%) had an unknown vaccine status. Overall, the incidence of nosocomial influenza was 0.5 per 100 admissions (0.35 per 1000 patient-days). The most frequent comorbidities were diabetes (20%), chronic respiratory diseases (19%), and malnutrition (17%). Fever (77%) and cough (66%) were the most frequent symptoms. Seventy-one percent of patients received antineuraminidases, 28% received antibiotics. Infectious complications such as pneumonia were reported in 9%. Overall, the all-cause mortality was 6%. CONCLUSION: The occurrence of nosocomial influenza underlines the importance of vaccinating patients and healthcare workers, rapidly recognizing community- or hospital-acquired cases, and applying adequate additional measures to prevent dissemination, including the timely administration of antineuraminidases to avoid antibiotic use (and misuse).
Subject(s)
Cross Infection , Epidemics , Influenza, Human , Cross Infection/epidemiology , Hospitals , Humans , Influenza, Human/epidemiology , Seasons , Switzerland/epidemiologyABSTRACT
BACKGROUND: Evidence of sustained improvement in hand hygiene compliance at the institutional level is scarce. AIM: To assess the impact and sustainability of a hospital-wide improvement programme on hand hygiene compliance of staff. METHODS: Analysis of trends of hand hygiene compliance for all clinical staff, measured through direct observation by trained observers, within a 450-bed multi-centre teaching hospital in the county of Neuchâtel, Switzerland. INTERVENTION: Implementation of a multi-modal improvement programme based on the World Health Organization (WHO) strategy, with the goal of reaching overall compliance of at least 80%. The strategy content included increasing access to alcohol hand rub; healthcare worker education; two-month interval compliance measurement; and hospital-wide open communication about ward-level results, point-of-care reminders, communication via a dedicated in-house newsletter and leadership engagement. The implementation phase was followed by a consolidation phase. FINDINGS: In total, 33,476 observations were collected from September 2012 to March 2014 (mean >3000 opportunities per audit). Overall compliance improved from 61.4% at baseline to 83.6% after the 18-month improvement programme (P<0.001), and was sustained at 85.3% 18 months later (i.e. 18 months after the programme finished) (P=0.08). The same trend (significant and clinically relevant improvement during the intervention, sustained after 18 months) was measured for all professional categories. CONCLUSIONS: This WHO-inspired improvement programme was associated with a significant improvement in hand hygiene compliance, globally and for each professional category. The results were sustained over an 18-month period.
Subject(s)
Cross Infection/prevention & control , Guideline Adherence/trends , Hand Hygiene/trends , Health Personnel , Disinfectants/administration & dosage , Health Communication , Health Education , Hospitals , Humans , SwitzerlandSubject(s)
HIV Infections , Scleritis , HIV , HIV Infections/complications , Humans , Scleritis/complications , Tomography, Optical Coherence , Visual AcuityABSTRACT
Coxiella burnetii infection (Q fever) is a widespread zoonosis with low endemicity in Switzerland, therefore no mandatory public report was required. A cluster of initially ten human cases of acute Q fever infections characterized by prolonged fever, asthenia and mild hepatitis occurred in 2012 in the terraced vineyard of Lavaux. Epidemiological investigations based on patients' interviews and veterinary investigations included environmental sampling as well as Coxiella-specific serological assay and molecular examinations (real-time PCR in vaginal secretions) of suspected sheep. These investigations demonstrated that 43% of sheep carried the bacteria whereas 30% exhibited anti-Coxiella antibodies. Mitigation measures, including limiting human contacts with the flock, hygiene measures, flock vaccination and a public official alert, have permitted the detection of four additional human cases and the avoidance of a much larger outbreak. Since November 2012, mandatory reporting of Q fever to Swiss public health authorities has been reintroduced. A close follow up of human cases will be necessary to identify chronic Q fever.
ABSTRACT
We report a patient suffering from cat-scratch disease limited to mediastinal lymphadenitis. Although rare, cat-scratch disease should be considered in the differential diagnosis of mediastinal lymphadenitis, especially when patients were exposed to cats.
Subject(s)
Cat-Scratch Disease/diagnosis , Cat-Scratch Disease/pathology , Lymphatic Diseases/diagnosis , Lymphatic Diseases/pathology , Mediastinal Diseases/diagnosis , Mediastinal Diseases/pathology , Female , Humans , Middle Aged , Positron-Emission Tomography , Radiography, Thoracic , Tomography, X-Ray ComputedABSTRACT
Effective empirical treatment is of paramount importance to improve the outcome of patients with Staphylococcus aureus bacteraemia. We aimed to evaluate a PCR-based rapid diagnosis of methicillin resistance (GeneXpert MRSA) after early detection of S. aureus bacteraemia using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Patients with a first episode of S. aureus bacteraemia identified using MALDI-TOF MS were randomized in a prospective interventional open study between October 2010 and August 2012. In the control group, antibiotic susceptibility testing was performed after MALDI-TOF MS identification on blood culture pellets. In the intervention group, a GeneXpert MRSA was performed after S. aureus identification. The primary outcome was the performance of GeneXpert MRSA directly on blood cultures. We then assessed the impact of early diagnosis of methicillin resistance on the empirical treatment. In all, 197 episodes of S. aureus bacteraemia were included in the study, of which 106 were included in the intervention group. Median time from MALDI-TOF MS identification to GeneXpert MRSA result was 97 min (range 25-250). Detection of methicillin resistance using GeneXpert MRSA had a sensitivity of 99% and a specificity of 100%. There was less unnecessary coverage of MRSA in the intervention group (17.1% versus 29.2%, p 0.09). GeneXpert MRSA was highly reliable in diagnosing methicillin resistance when performed directly on positive blood cultures. This could help to avoid unnecessary prescriptions of anti-MRSA agents and promote the introduction of earlier adequate coverage in unsuspected cases.
Subject(s)
Bacteremia/diagnosis , Bacteriological Techniques/methods , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Polymerase Chain Reaction/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Staphylococcal Infections/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Methicillin-Resistant Staphylococcus aureus/chemistry , Methicillin-Resistant Staphylococcus aureus/genetics , Middle Aged , Prospective Studies , Sensitivity and Specificity , Staphylococcal Infections/microbiology , Time Factors , Young AdultSubject(s)
Arthritis, Infectious/etiology , Diabetes Mellitus, Type 2/complications , Surgical Wound Infection/complications , Tooth Extraction/adverse effects , Aged , Arthritis, Infectious/diagnosis , Contraindications , Diabetes Mellitus, Type 2/surgery , Humans , Male , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Streptococcal Infections/etiology , Streptococcus milleri Group/isolation & purification , Streptococcus milleri Group/physiology , Surgical Wound Infection/diagnosisABSTRACT
When patients return from the Tropics, parasitic infections are immediately being considered when they present with digestive symptoms. Using three examples, we describe parasitic infections acquired in Switzerland simulating other more common community pathologies, which in each case resulted in delayed diagnosis. Awareness among primary care physicians of these rare diseases, whose treatment may be unfamiliar, should improve the care of patients and avoid such late presentations.
Subject(s)
Parasitic Diseases/diagnosis , Animals , Antiparasitic Agents/therapeutic use , Humans , Parasitic Diseases/drug therapy , Travel , Tropical ClimateABSTRACT
Uncomplicated urinary tract infections are commonly encountered in primary care and frequently lead to empirical antibiotic prescriptions. The development of antibiotic resistance in the community explains treatment failures observed with commonly-prescribed drugs such as quinolones and co-trimoxazole. This article describes the epidemiology of antibiotic resistance among pathogens causing uncomplicated urinary tract infections and the consequences in terms of recommendations for empirical antibiotic therapy.
Subject(s)
Biota , Drug Resistance, Microbial/physiology , Internal Medicine/trends , Urinary Tract Infections/therapy , Anti-Bacterial Agents/therapeutic use , Humans , Internal Medicine/methods , Metagenome/physiology , Practice Guidelines as Topic , Practice Patterns, Physicians'/statistics & numerical data , Practice Patterns, Physicians'/trends , Pyelonephritis/etiology , Pyelonephritis/microbiology , Pyelonephritis/therapy , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiologyABSTRACT
HIV infection is becoming a chronic disease, due to decreased mortality induced by the introduction of combined antiviral treatments. The HIV positive population is aging progressively. HIV infection in the elderly has certain specificities, including a late initial diagnosis, a less marked immune response to treatment and the potential association of multiple comorbidities associated with HIV infection and aging. These factors may affect the quality of life of elderly patients and ultimately lead to increased functional dependence. Screening and specific treatment of comorbidities associated with HIV and aging are particularly recommended.
Subject(s)
HIV Infections/complications , HIV Infections/diagnosis , Aged , Anti-Retroviral Agents/administration & dosage , Anti-Retroviral Agents/adverse effects , Cognition Disorders/etiology , Comorbidity , Delayed Diagnosis , HIV Infections/drug therapy , HIV Infections/epidemiology , HumansABSTRACT
AIMS: To investigate the relationship of alcohol consumption with the metabolic syndrome and diabetes in a population-based study with high mean alcohol consumption. Few data exist on these conditions in high-risk drinkers. METHODS: In 6172 adults aged 35-75 years, alcohol consumption was categorized as 0, 1-6, 7-13, 14-20, 21-27, 28-34 and ≥ 35 drinks/week or as non-drinkers (0), low-risk (1-13), medium-to-high-risk (14-34) and very-high-risk (≥ 35) drinkers. Alcohol consumption was objectively confirmed by biochemical tests. In multivariate analysis, we assessed the relationship of alcohol consumption with adjusted prevalence of the metabolic syndrome, diabetes and insulin resistance, determined with the homeostasis model assessment of insulin resistance (HOMA-IR). RESULTS: Seventy-three per cent of participants consumed alcohol, 16% were medium-to-high-risk drinkers and 2% very-high-risk drinkers. In multivariate analysis, the prevalence of the metabolic syndrome, diabetes and mean HOMA-IR decreased with low-risk drinking and increased with high-risk drinking. Adjusted prevalence of the metabolic syndrome was 24% in non-drinkers, 19% in low-risk (P<0.001 vs. non-drinkers), 20% in medium-to-high-risk and 29% in very-high-risk drinkers (P=0.005 vs. low-risk). Adjusted prevalence of diabetes was 6.0% in non-drinkers, 3.6% in low-risk (P<0.001 vs. non-drinkers), 3.8% in medium-to-high-risk and 6.7% in very-high-risk drinkers (P=0.046 vs. low-risk). Adjusted HOMA-IR was 2.47 in non-drinkers, 2.14 in low-risk (P<0.001 vs. non-drinkers), 2.27 in medium-to-high-risk and 2.53 in very-high-risk drinkers (P=0.04 vs. low-risk). These relationships did not differ according to beverage types. CONCLUSIONS: Alcohol has a U-shaped relationship with the metabolic syndrome, diabetes and HOMA-IR, without differences between beverage types.
Subject(s)
Alcohol Drinking/epidemiology , Cardiovascular Diseases/epidemiology , Diabetes Mellitus/epidemiology , Diabetic Angiopathies/epidemiology , Metabolic Syndrome/epidemiology , Adult , Aged , Alcohol Drinking/adverse effects , Cardiovascular Diseases/prevention & control , Cross-Sectional Studies , Diabetic Angiopathies/prevention & control , Female , Humans , Insulin Resistance/physiology , Male , Metabolic Syndrome/complications , Middle Aged , Prevalence , Risk Factors , Switzerland/epidemiologyABSTRACT
Point-of-care (POC) tests offer potentially substantial benefits for the management of infectious diseases, mainly by shortening the time to result and by making the test available at the bedside or at remote care centres. Commercial POC tests are already widely available for the diagnosis of bacterial and viral infections and for parasitic diseases, including malaria. Infectious diseases specialists and clinical microbiologists should be aware of the indications and limitations of each rapid test, so that they can use them appropriately and correctly interpret their results. The clinical applications and performance of the most relevant and commonly used POC tests are reviewed. Some of these tests exhibit insufficient sensitivity, and should therefore be coupled to confirmatory tests when the results are negative (e.g. Streptococcus pyogenes rapid antigen detection test), whereas the results of others need to be confirmed when positive (e.g. malaria). New molecular-based tests exhibit better sensitivity and specificity than former immunochromatographic assays (e.g. Streptococcus agalactiae detection). In the coming years, further evolution of POC tests may lead to new diagnostic approaches, such as panel testing, targeting not just a single pathogen, but all possible agents suspected in a specific clinical setting. To reach this goal, the development of serology-based and/or molecular-based microarrays/multiplexed tests will be needed. The availability of modern technology and new microfluidic devices will provide clinical microbiologists with the opportunity to be back at the bedside, proposing a large variety of POC tests that will allow quicker diagnosis and improved patient care.
Subject(s)
Clinical Laboratory Techniques/methods , Communicable Diseases/diagnosis , Parasitology/methods , Point-of-Care Systems , Virology/methods , Animals , Bacteria/classification , Bacteria/isolation & purification , Humans , Parasites/classification , Parasites/isolation & purification , Sensitivity and Specificity , Viruses/classification , Viruses/isolation & purificationABSTRACT
HIV-1 diagnosis is usually based on the detection of specific antibodies, appearing in a time-determined pattern following the infection. We describe a prolonged HIV-1 seroconversion in an elite controller (defined as having HIV-1 RNA persistently <50copies/ml while untreated). HIV-1 diagnosis was delayed and complicated by this atypical evolution.
Subject(s)
HIV Seropositivity/diagnosis , HIV-1/immunology , AIDS Serodiagnosis , Adult , Antibodies, Viral/blood , HIV Seropositivity/immunology , HIV Seropositivity/virology , Humans , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/virology , Male , RNA, Viral/bloodABSTRACT
Twenty-five years after the description of the first cases of AIDS, the HIV pandemic remains a major public health problem. Although often described as a single epidemic, there are many distinct epidemiological situations. Individual-level risks are at the center of this evolution and influenced by social, economic and political contexts. The overall situation in Europe and the Americas seems stable in recent years. However, the generalized epidemics in sub-Saharan Africa continue to spread and new hidden epidemic foci involving specific risk populations are emerging throughout the rest of the world. A multidimensional approach, tailored to the particular socio-cultural context, is essential to control these complex and diversified epidemics.
Subject(s)
HIV Infections/epidemiology , Africa/epidemiology , Europe/epidemiology , Humans , Risk Factors , Social Conditions , United States/epidemiologyABSTRACT
Caprylic acid (octanoic acid), has been used for over 50 years as a stabilizer of human albumin during pasteurization. In addition caprylic acid is of great interest, by providing the advantage of purifying mammalian immunoglobulins and clearing viruses infectivity in a single step. Exploiting these two properties, we sequentially used the caprylic acid precipitation and the pasteurization to purify horse hyperimmune globulins used in the manufacturing of Sérocytol. To evaluate the effectiveness of the process for the removal/inactivation of viruses, spiking studies were carried out for each dedicated step. Bovine viral diarrhoea virus (BVDV), pseudorabies virus (PRV), encephalomyocarditis virus (EMCV) and minute virus of mice (MVM) were used for the virological validation. Our data show that the treatment with caprylic acid 5% (v/v) can effectively be used as well to purify or to ensure viral safety of immunoglobulins. Caprylic acid precipitation was very efficient in removing and/or inactivating enveloped viruses (PRV, BVDV) and moderately efficient against non-enveloped viruses (MVM, ECMV). However the combination with the pasteurization ensured an efficient protection against both enveloped and non-enveloped viruses. So that viruses surviving to the caprylic acid precipitation will be neutralized by pasteurization. Significant log reduction were achieved > or =9 log(10) for enveloped viruses and 4 log(10) for non-enveloped viruses, providing the evidence of a margin of viral safety achieved by our manufacturing process. Its a simple and non-expensive manufacturing process of immunoglobulins easily validated that we have adapted to a large production scale with a programmable operating system.